ArticleFrontiers in oncology2024

Development of transcriptomic tools for predicting the response to individual drug of the mFOLFIRINOX regimen in patients with metastatic pancreatic cancer.

Nicolas Fraunhoffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.